Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

Incidence of cardiovascular disease in familial combined hyperlipidemia: A 15-year follow-up study.

Luijten J, van Greevenbroek MMJ, Schaper NC, Meex SJR, van der Steen C, Meijer LJ, de Boer D, de Graaf J, Stehouwer CDA, Brouwers MCGJ.

Atherosclerosis. 2019 Jan;280:1-6. doi: 10.1016/j.atherosclerosis.2018.11.013. Epub 2018 Nov 8.

PMID:
30448567
2.

Association of maternal prenatal smoking GFI1-locus and cardio-metabolic phenotypes in 18,212 adults.

Parmar P, Lowry E, Cugliari G, Suderman M, Wilson R, Karhunen V, Andrew T, Wiklund P, Wielscher M, Guarrera S, Teumer A, Lehne B, Milani L, de Klein N, Mishra PP, Melton PE, Mandaviya PR, Kasela S, Nano J, Zhang W, Zhang Y, Uitterlinden AG, Peters A, Schöttker B, Gieger C, Anderson D, Boomsma DI, Grabe HJ, Panico S, Veldink JH, van Meurs JBJ, van den Berg L, Beilin LJ, Franke L, Loh M, van Greevenbroek MMJ, Nauck M, Kähönen M, Hurme MA, Raitakari OT, Franco OH, Slagboom PE, van der Harst P, Kunze S, Felix SB, Zhang T, Chen W, Mori TA, Bonnefond A, Heijmans BT; BIOS Consortium, Muka T, Kooner JS, Fischer K, Waldenberger M, Froguel P, Huang RC, Lehtimäki T, Rathmann W, Relton CL, Matullo G, Brenner H, Verweij N, Li S, Chambers JC, Järvelin MR, Sebert S; GLOBAL Meth QTL Consortium.

EBioMedicine. 2018 Dec;38:206-216. doi: 10.1016/j.ebiom.2018.10.066. Epub 2018 Nov 13.

3.

Plasma lipid profiling of tissue-specific insulin resistance in human obesity.

van der Kolk BW, Vogelzangs N, Jocken JWE, Valsesia A, Hankemeier T, Astrup A, Saris WHM, Arts ICW, van Greevenbroek MMJ, Blaak EE; DiOGenes consortium.

Int J Obes (Lond). 2018 Sep 21. doi: 10.1038/s41366-018-0189-8. [Epub ahead of print]

PMID:
30242234
4.

Autosomal genetic variation is associated with DNA methylation in regions variably escaping X-chromosome inactivation.

Luijk R, Wu H, Ward-Caviness CK, Hannon E, Carnero-Montoro E, Min JL, Mandaviya P, Müller-Nurasyid M, Mei H, van der Maarel SM; BIOS Consortium, Relton C, Mill J, Waldenberger M, Bell JT, Jansen R, Zhernakova A, Franke L, 't Hoen PAC, Boomsma DI, van Duijn CM, van Greevenbroek MMJ, Veldink JH, Wijmenga C, van Meurs J, Daxinger L, Slagboom PE, van Zwet EW, Heijmans BT.

Nat Commun. 2018 Sep 14;9(1):3738. doi: 10.1038/s41467-018-05714-3.

5.

Complement C3 and C4, but not their regulators or activated products, are associated with incident metabolic syndrome: the CODAM study.

Xin Y, Hertle E, van der Kallen CJH, Schalkwijk CG, Stehouwer CDA, van Greevenbroek MMJ.

Endocrine. 2018 Dec;62(3):617-627. doi: 10.1007/s12020-018-1712-3. Epub 2018 Aug 21.

6.

Blood Metabolomic Measures Associate With Present and Future Glycemic Control in Type 2 Diabetes.

't Hart LM, Vogelzangs N, Mook-Kanamori DO, Brahimaj A, Nano J, van der Heijden AAWA, Willems van Dijk K, Slieker RC, Steyerberg EW, Ikram MA, Beekman M, Boomsma DI, van Duijn CM, Slagboom PE, Stehouwer CDA, Schalkwijk CG, Arts ICW, Dekker JM, Dehghan A, Muka T, van der Kallen CJH, Nijpels G, van Greevenbroek MMJ.

J Clin Endocrinol Metab. 2018 Dec 1;103(12):4569-4579. doi: 10.1210/jc.2018-01165.

PMID:
30113659
7.

Genome-wide identification of directed gene networks using large-scale population genomics data.

Luijk R, Dekkers KF, van Iterson M, Arindrarto W, Claringbould A, Hop P, Boomsma DI, van Duijn CM, van Greevenbroek MMJ, Veldink JH, Wijmenga C, Franke L, 't Hoen PAC, Jansen R, van Meurs J, Mei H, Slagboom PE, Heijmans BT, van Zwet EW; BIOS (Biobank-based Integrative Omics Study) Consortium.

Nat Commun. 2018 Aug 6;9(1):3097. doi: 10.1038/s41467-018-05452-6.

8.

Classical Pathway of Complement Activation: Longitudinal Associations of C1q and C1-INH With Cardiovascular Outcomes: The CODAM Study (Cohort on Diabetes and Atherosclerosis Maastricht)-Brief Report.

Hertle E, Arts ICW, van der Kallen CJH, Feskens EJM, Schalkwijk CG, Stehouwer CDA, van Greevenbroek MMJ.

Arterioscler Thromb Vasc Biol. 2018 May;38(5):1242-1244. doi: 10.1161/ATVBAHA.118.310806. Epub 2018 Mar 22.

PMID:
29567681
9.

Prospective associations of dietary carbohydrate, fat, and protein intake with β-cell function in the CODAM study.

den Biggelaar LJCJ, Eussen SJPM, Sep SJS, Mari A, Ferrannini E, van Greevenbroek MM, van der Kallen CJ, Schalkwijk CG, Arts ICW, Stehouwer CDA, Dagnelie PC.

Eur J Nutr. 2018 Mar 10. doi: 10.1007/s00394-018-1644-y. [Epub ahead of print]

PMID:
29525890
10.

Circulating Polyunsaturated Fatty Acids as Biomarkers for Dietary Intake across Subgroups: The CODAM and Hoorn Studies.

Wanders AJ, Alssema M, De Hoon SEM, Feskens EJM, van Woudenbergh GJ, van der Kallen CJ, Zock PL, Refsum H, Drevon CA, Elshorbagy A, Schalkwijk CG, Stehouwer CDA, Dekker JM, van Greevenbroek MMJ.

Ann Nutr Metab. 2018;72(2):117-125. doi: 10.1159/000486244. Epub 2018 Jan 25.

PMID:
29393106
11.

Dietary intake of advanced glycation endproducts is associated with higher levels of advanced glycation endproducts in plasma and urine: The CODAM study.

Scheijen JLJM, Hanssen NMJ, van Greevenbroek MM, Van der Kallen CJ, Feskens EJM, Stehouwer CDA, Schalkwijk CG.

Clin Nutr. 2018 Jun;37(3):919-925. doi: 10.1016/j.clnu.2017.03.019. Epub 2017 Mar 23.

PMID:
29381139
12.

Longitudinal associations of the alternative and terminal pathways of complement activation with adiposity: The CODAM study.

Xin Y, Hertle E, van der Kallen CJH, Schalkwijk CG, Stehouwer CDA, van Greevenbroek MMJ.

Obes Res Clin Pract. 2018 May - Jun;12(3):286-292. doi: 10.1016/j.orcp.2017.11.002. Epub 2017 Nov 22.

PMID:
29174517
13.

Genetically defined elevated homocysteine levels do not result in widespread changes of DNA methylation in leukocytes.

Mandaviya PR, Joehanes R, Aïssi D, Kühnel B, Marioni RE, Truong V, Stolk L, Beekman M, Bonder MJ, Franke L, Gieger C, Huan T, Ikram MA, Kunze S, Liang L, Lindemans J, Liu C, McRae AF, Mendelson MM, Müller-Nurasyid M, Peters A, Slagboom PE, Starr JM, Trégouët DA, Uitterlinden AG, van Greevenbroek MMJ, van Heemst D, van Iterson M, Wells PS, Yao C, Deary IJ, Gagnon F, Heijmans BT, Levy D, Morange PE, Waldenberger M, Heil SG, van Meurs JBJ; CHARGE Consortium Epigenetics group and BIOS Consortium.

PLoS One. 2017 Oct 30;12(10):e0182472. doi: 10.1371/journal.pone.0182472. eCollection 2017.

14.

Homocysteine levels associate with subtle changes in leukocyte DNA methylation: an epigenome-wide analysis.

Mandaviya PR, Aïssi D, Dekkers KF, Joehanes R, Kasela S, Truong V, Stolk L, Heemst DV, Ikram MA, Lindemans J, Slagboom PE, Trégouët DA, Uitterlinden AG, Wei C, Wells P, Gagnon F, van Greevenbroek MM, Heijmans BT, Milani L, Morange PE, van Meurs JB, Heil SG; BIOS Consortium.

Epigenomics. 2017 Nov;9(11):1403-1422. doi: 10.2217/epi-2017-0038. Epub 2017 Oct 9.

PMID:
28990796
15.

BclI Glucocorticoid Receptor Polymorphism in Relation to Arterial Stiffening and Cardiac Structure and Function: The Hoorn and CODAM Studies.

van Moorsel D, Henry RM, Schaper NC, van Greevenbroek MM, van Rossum EF, 't Hart LM, Schalkwijk CG, van der Kallen CJ, Dekker JM, Stehouwer CD, Havekes B.

Am J Hypertens. 2017 Mar 1;30(3):286-294. doi: 10.1093/ajh/hpw196.

PMID:
28096152
16.

Discriminatory ability of simple OGTT-based beta cell function indices for prediction of prediabetes and type 2 diabetes: the CODAM study.

den Biggelaar LJ, Sep SJ, Eussen SJ, Mari A, Ferrannini E, van Greevenbroek MM, van der Kallen CJ, Schalkwijk CG, Stehouwer CD, Dagnelie PC.

Diabetologia. 2017 Mar;60(3):432-441. doi: 10.1007/s00125-016-4165-3. Epub 2016 Dec 8.

PMID:
27933333
17.

Disease variants alter transcription factor levels and methylation of their binding sites.

Bonder MJ, Luijk R, Zhernakova DV, Moed M, Deelen P, Vermaat M, van Iterson M, van Dijk F, van Galen M, Bot J, Slieker RC, Jhamai PM, Verbiest M, Suchiman HE, Verkerk M, van der Breggen R, van Rooij J, Lakenberg N, Arindrarto W, Kielbasa SM, Jonkers I, van 't Hof P, Nooren I, Beekman M, Deelen J, van Heemst D, Zhernakova A, Tigchelaar EF, Swertz MA, Hofman A, Uitterlinden AG, Pool R, van Dongen J, Hottenga JJ, Stehouwer CD, van der Kallen CJ, Schalkwijk CG, van den Berg LH, van Zwet EW, Mei H, Li Y, Lemire M, Hudson TJ; BIOS Consortium, Slagboom PE, Wijmenga C, Veldink JH, van Greevenbroek MM, van Duijn CM, Boomsma DI, Isaacs A, Jansen R, van Meurs JB, 't Hoen PA, Franke L, Heijmans BT.

Nat Genet. 2017 Jan;49(1):131-138. doi: 10.1038/ng.3721. Epub 2016 Dec 5.

PMID:
27918535
18.

Identification of context-dependent expression quantitative trait loci in whole blood.

Zhernakova DV, Deelen P, Vermaat M, van Iterson M, van Galen M, Arindrarto W, van 't Hof P, Mei H, van Dijk F, Westra HJ, Bonder MJ, van Rooij J, Verkerk M, Jhamai PM, Moed M, Kielbasa SM, Bot J, Nooren I, Pool R, van Dongen J, Hottenga JJ, Stehouwer CD, van der Kallen CJ, Schalkwijk CG, Zhernakova A, Li Y, Tigchelaar EF, de Klein N, Beekman M, Deelen J, van Heemst D, van den Berg LH, Hofman A, Uitterlinden AG, van Greevenbroek MM, Veldink JH, Boomsma DI, van Duijn CM, Wijmenga C, Slagboom PE, Swertz MA, Isaacs A, van Meurs JB, Jansen R, Heijmans BT, 't Hoen PA, Franke L.

Nat Genet. 2017 Jan;49(1):139-145. doi: 10.1038/ng.3737. Epub 2016 Dec 5.

PMID:
27918533
19.

Dysfunctional adipose tissue and low-grade inflammation in the management of the metabolic syndrome: current practices and future advances.

van Greevenbroek MM, Schalkwijk CG, Stehouwer CD.

F1000Res. 2016 Oct 13;5. pii: F1000 Faculty Rev-2515. eCollection 2016. Review.

20.

A Common Gene Variant in Glucokinase Regulatory Protein Interacts With Glucose Metabolism on Diabetic Dyslipidemia: the Combined CODAM and Hoorn Studies.

Simons N, Dekker JM, van Greevenbroek MM, Nijpels G, 't Hart LM, van der Kallen CJ, Schalkwijk CG, Schaper NC, Stehouwer CD, Brouwers MC.

Diabetes Care. 2016 Oct;39(10):1811-7. doi: 10.2337/dc16-0153.

PMID:
27660121
21.

Age-related accrual of methylomic variability is linked to fundamental ageing mechanisms.

Slieker RC, van Iterson M, Luijk R, Beekman M, Zhernakova DV, Moed MH, Mei H, van Galen M, Deelen P, Bonder MJ, Zhernakova A, Uitterlinden AG, Tigchelaar EF, Stehouwer CD, Schalkwijk CG, van der Kallen CJ, Hofman A, van Heemst D, de Geus EJ, van Dongen J, Deelen J, van den Berg LH, van Meurs J, Jansen R, 't Hoen PA, Franke L, Wijmenga C, Veldink JH, Swertz MA, van Greevenbroek MM, van Duijn CM, Boomsma DI; BIOS consortium, Slagboom PE, Heijmans BT.

Genome Biol. 2016 Sep 22;17(1):191.

22.

Blood lipids influence DNA methylation in circulating cells.

Dekkers KF, van Iterson M, Slieker RC, Moed MH, Bonder MJ, van Galen M, Mei H, Zhernakova DV, van den Berg LH, Deelen J, van Dongen J, van Heemst D, Hofman A, Hottenga JJ, van der Kallen CJ, Schalkwijk CG, Stehouwer CD, Tigchelaar EF, Uitterlinden AG, Willemsen G, Zhernakova A, Franke L, 't Hoen PA, Jansen R, van Meurs J, Boomsma DI, van Duijn CM, van Greevenbroek MM, Veldink JH, Wijmenga C; BIOS Consortium, van Zwet EW, Slagboom PE, Jukema JW, Heijmans BT.

Genome Biol. 2016 Jun 27;17(1):138. doi: 10.1186/s13059-016-1000-6.

23.

Impaired HDL cholesterol efflux in metabolic syndrome is unrelated to glucose tolerance status: the CODAM study.

Annema W, Dikkers A, de Boer JF, van Greevenbroek MM, van der Kallen CJ, Schalkwijk CG, Stehouwer CD, Dullaart RP, Tietge UJ.

Sci Rep. 2016 Jun 8;6:27367. doi: 10.1038/srep27367.

24.

Distinct Longitudinal Associations of MBL, MASP-1, MASP-2, MASP-3, and MAp44 With Endothelial Dysfunction and Intima-Media Thickness: The Cohort on Diabetes and Atherosclerosis Maastricht (CODAM) Study.

Hertle E, Arts IC, van der Kallen CJ, Feskens EJ, Schalkwijk CG, Hoffmann-Petersen IT, Thiel S, Stehouwer CD, van Greevenbroek MM.

Arterioscler Thromb Vasc Biol. 2016 Jun;36(6):1278-85. doi: 10.1161/ATVBAHA.115.306552. Epub 2016 Apr 7.

PMID:
27055907
25.

Protein-Bound Plasma Nε-(Carboxymethyl)lysine Is Inversely Associated With Central Obesity and Inflammation and Significantly Explain a Part of the Central Obesity-Related Increase in Inflammation: The Hoorn and CODAM Studies.

Gaens KH, Ferreira I, van de Waarenburg MP, van Greevenbroek MM, van der Kallen CJ, Dekker JM, Nijpels G, Rensen SS, Stehouwer CD, Schalkwijk CG.

Arterioscler Thromb Vasc Biol. 2015 Dec;35(12):2707-13. doi: 10.1161/ATVBAHA.115.306106. Epub 2015 Oct 8.

PMID:
26449750
26.

The alternative complement pathway is longitudinally associated with adverse cardiovascular outcomes. The CODAM study.

Hertle E, Arts IC, van der Kallen CJ, Feskens EJ, Schalkwijk CG, Stehouwer CD, van Greevenbroek MM.

Thromb Haemost. 2016 Jan;115(2):446-57. doi: 10.1160/TH15-05-0439. Epub 2015 Oct 8.

PMID:
26446431
27.

BclI glucocorticoid receptor polymorphism in relation to cardiovascular variables: the Hoorn and CODAM studies.

van Moorsel D, van Greevenbroek MM, Schaper NC, Henry RM, Geelen CC, van Rossum EF, Nijpels G, 't Hart LM, Schalkwijk CG, van der Kallen CJ, Sauerwein HP, Dekker JM, Stehouwer CD, Havekes B.

Eur J Endocrinol. 2015 Oct;173(4):455-64. doi: 10.1530/EJE-15-0381. Epub 2015 Jul 2.

PMID:
26139210
28.

A healthy diet is associated with less endothelial dysfunction and less low-grade inflammation over a 7-year period in adults at risk of cardiovascular disease.

van Bussel BC, Henry RM, Ferreira I, van Greevenbroek MM, van der Kallen CJ, Twisk JW, Feskens EJ, Schalkwijk CG, Stehouwer CD.

J Nutr. 2015 Mar;145(3):532-40. doi: 10.3945/jn.114.201236. Epub 2014 Dec 31.

PMID:
25733469
29.

Post-Glucose Load Plasma α-Dicarbonyl Concentrations Are Increased in Individuals With Impaired Glucose Metabolism and Type 2 Diabetes: The CODAM Study.

Maessen DE, Hanssen NM, Scheijen JL, van der Kallen CJ, van Greevenbroek MM, Stehouwer CD, Schalkwijk CG.

Diabetes Care. 2015 May;38(5):913-20. doi: 10.2337/dc14-2605. Epub 2015 Feb 20.

PMID:
25710921
30.

Iron metabolism is prospectively associated with insulin resistance and glucose intolerance over a 7-year follow-up period: the CODAM study.

Wlazlo N, van Greevenbroek MM, Ferreira I, Jansen EH, Feskens EJ, van der Kallen CJ, Schalkwijk CG, Bravenboer B, Stehouwer CD.

Acta Diabetol. 2015 Apr;52(2):337-48. doi: 10.1007/s00592-014-0646-3. Epub 2014 Oct 1.

PMID:
25267079
31.

The complement system in human cardiometabolic disease.

Hertle E, Stehouwer CD, van Greevenbroek MM.

Mol Immunol. 2014 Oct;61(2):135-48. doi: 10.1016/j.molimm.2014.06.031. Epub 2014 Jul 10. Review.

PMID:
25017306
32.

A metabolomic profile is associated with the risk of incident coronary heart disease.

Vaarhorst AA, Verhoeven A, Weller CM, Böhringer S, Göraler S, Meissner A, Deelder AM, Henneman P, Gorgels AP, van den Brandt PA, Schouten LJ, van Greevenbroek MM, Merry AH, Verschuren WM, van den Maagdenberg AM, van Dijk KW, Isaacs A, Boomsma D, Oostra BA, van Duijn CM, Jukema JW, Boer JM, Feskens E, Heijmans BT, Slagboom PE.

Am Heart J. 2014 Jul;168(1):45-52.e7. doi: 10.1016/j.ahj.2014.01.019. Epub 2014 Apr 4.

33.

The cross-sectional association between uric acid and atherosclerosis and the role of low-grade inflammation: the CODAM study.

Wijnands JM, Boonen A, Dagnelie PC, van Greevenbroek MM, van der Kallen CJ, Ferreira I, Schalkwijk CG, Feskens EJ, Stehouwer CD, van der Linden S, Arts IC.

Rheumatology (Oxford). 2014 Nov;53(11):2053-62. doi: 10.1093/rheumatology/keu239. Epub 2014 Jun 10.

PMID:
24917566
34.

Familial combined hyperlipidemia: from molecular insights to tailored therapy.

van Greevenbroek MM, Stalenhoef AF, de Graaf J, Brouwers MC.

Curr Opin Lipidol. 2014 Jun;25(3):176-82. doi: 10.1097/MOL.0000000000000068. Review.

PMID:
24811296
35.

Complement activation products C5a and sC5b-9 are associated with low-grade inflammation and endothelial dysfunction, but not with atherosclerosis in a cross-sectional analysis: the CODAM study.

Hertle E, van Greevenbroek MM, Arts IC, van der Kallen CJ, Feskens EJ, Schalkwijk CG, Stehouwer CD.

Int J Cardiol. 2014 Jun 15;174(2):400-3. doi: 10.1016/j.ijcard.2014.04.057. Epub 2014 Apr 13. No abstract available.

PMID:
24794956
36.

Complement factor 3 is associated with insulin resistance and with incident type 2 diabetes over a 7-year follow-up period: the CODAM Study.

Wlazlo N, van Greevenbroek MM, Ferreira I, Feskens EJ, van der Kallen CJ, Schalkwijk CG, Bravenboer B, Stehouwer CD.

Diabetes Care. 2014 Jul;37(7):1900-9. doi: 10.2337/dc13-2804. Epub 2014 Apr 23.

PMID:
24760264
37.

Nε-(carboxymethyl)lysine-receptor for advanced glycation end product axis is a key modulator of obesity-induced dysregulation of adipokine expression and insulin resistance.

Gaens KH, Goossens GH, Niessen PM, van Greevenbroek MM, van der Kallen CJ, Niessen HW, Rensen SS, Buurman WA, Greve JW, Blaak EE, van Zandvoort MA, Bierhaus A, Stehouwer CD, Schalkwijk CG.

Arterioscler Thromb Vasc Biol. 2014 Jun;34(6):1199-208. doi: 10.1161/ATVBAHA.113.302281. Epub 2014 Apr 10.

PMID:
24723555
38.

Distinct associations of complement C3a and its precursor C3 with atherosclerosis and cardiovascular disease. The CODAM study.

Hertle E, van Greevenbroek MM, Arts IC, van der Kallen CJ, Geijselaers SL, Feskens EJ, Jansen EH, Schalkwijk CG, Stehouwer CD.

Thromb Haemost. 2014 Jun;111(6):1102-11. doi: 10.1160/TH13-10-0831. Epub 2014 Feb 6.

PMID:
24500020
39.

Circulating PCSK9 is a strong determinant of plasma triacylglycerols and total cholesterol in homozygous carriers of apolipoprotein ε2.

Brouwers MC, van Greevenbroek MM, Konrad RJ, Troutt JS, Schaper NC, Stehouwer CD.

Clin Sci (Lond). 2014 May;126(9):679-84. doi: 10.1042/CS20130556.

PMID:
24308640
40.

Complement c3 is inversely associated with habitual intake of provitamin A but not with dietary fat, fatty acids, or vitamin E in middle-aged to older white adults and positively associated with intake of retinol in middle-aged to older white women.

van Greevenbroek MM, Arts IC, van der Kallen CJ, Dagnelie PC, Ferreira I, Jansen E, Schalkwijk CG, Feskens EJ, Stehouwer CD.

J Nutr. 2014 Jan;144(1):61-7. doi: 10.3945/jn.113.181628. Epub 2013 Oct 30.

PMID:
24174622
41.

Adapted dietary inflammatory index and its association with a summary score for low-grade inflammation and markers of glucose metabolism: the Cohort study on Diabetes and Atherosclerosis Maastricht (CODAM) and the Hoorn study.

van Woudenbergh GJ, Theofylaktopoulou D, Kuijsten A, Ferreira I, van Greevenbroek MM, van der Kallen CJ, Schalkwijk CG, Stehouwer CD, Ocké MC, Nijpels G, Dekker JM, Blaak EE, Feskens EJ.

Am J Clin Nutr. 2013 Dec;98(6):1533-42. doi: 10.3945/ajcn.112.056333. Epub 2013 Oct 23.

PMID:
24153342
42.

Plasma levels of advanced glycation endproducts Nε-(carboxymethyl)lysine, Nε-(carboxyethyl)lysine, and pentosidine are not independently associated with cardiovascular disease in individuals with or without type 2 diabetes: the Hoorn and CODAM studies.

Hanssen NM, Engelen L, Ferreira I, Scheijen JL, Huijberts MS, van Greevenbroek MM, van der Kallen CJ, Dekker JM, Nijpels G, Stehouwer CD, Schalkwijk CG.

J Clin Endocrinol Metab. 2013 Aug;98(8):E1369-73. doi: 10.1210/jc.2013-1068. Epub 2013 Jun 18.

PMID:
23780372
43.

Obesity-associated low-grade inflammation in type 2 diabetes mellitus: causes and consequences.

van Greevenbroek MM, Schalkwijk CG, Stehouwer CD.

Neth J Med. 2013 May;71(4):174-87. Review.

44.

Activated complement factor 3 is associated with liver fat and liver enzymes: the CODAM study.

Wlazlo N, van Greevenbroek MM, Ferreira I, Jansen EH, Feskens EJ, van der Kallen CJ, Schalkwijk CG, Bravenboer B, Stehouwer CD.

Eur J Clin Invest. 2013 Jul;43(7):679-88. doi: 10.1111/eci.12093. Epub 2013 Apr 16.

PMID:
23586841
45.

Diabetes mellitus at the time of diagnosis of cirrhosis is associated with higher incidence of spontaneous bacterial peritonitis, but not with increased mortality.

Wlazlo N, van Greevenbroek MM, Curvers J, Schoon EJ, Friederich P, Twisk JW, Bravenboer B, Stehouwer CD.

Clin Sci (Lond). 2013 Oct;125(7):341-8. doi: 10.1042/CS20120596.

PMID:
23566037
46.

Multiple inflammatory biomarker detection in a prospective cohort study: a cross-validation between well-established single-biomarker techniques and an electrochemiluminescense-based multi-array platform.

van Bussel BC, Ferreira I, van de Waarenburg MP, van Greevenbroek MM, van der Kallen CJ, Henry RM, Feskens EJ, Stehouwer CD, Schalkwijk CG.

PLoS One. 2013;8(3):e58576. doi: 10.1371/journal.pone.0058576. Epub 2013 Mar 5.

47.

BclI glucocorticoid receptor polymorphism is associated with greater body fatness: the Hoorn and CODAM studies.

Geelen CC, van Greevenbroek MM, van Rossum EF, Schaper NC, Nijpels G, 't Hart LM, Schalkwijk CG, Ferreira I, van der Kallen CJ, Sauerwein HP, Dekker JM, Stehouwer CD, Havekes B.

J Clin Endocrinol Metab. 2013 Mar;98(3):E595-9. doi: 10.1210/jc.2012-3442. Epub 2013 Feb 7.

PMID:
23393177
48.

Plasma proprotein convertase subtilisin kexin type 9 levels are related to markers of cholesterol synthesis in familial combined hyperlipidemia.

Brouwers MC, Konrad RJ, van Himbergen TM, Isaacs A, Otokozawa S, Troutt JS, Schaefer EJ, van Greevenbroek MM, Stalenhoef AF, de Graaf J.

Nutr Metab Cardiovasc Dis. 2013 Nov;23(11):1115-21. doi: 10.1016/j.numecd.2012.11.008. Epub 2013 Jan 18.

PMID:
23333725
49.

Up-regulation of the complement system in subcutaneous adipocytes from nonobese, hypertriglyceridemic subjects is associated with adipocyte insulin resistance.

van Greevenbroek MM, Ghosh S, van der Kallen CJ, Brouwers MC, Schalkwijk CG, Stehouwer CD.

J Clin Endocrinol Metab. 2012 Dec;97(12):4742-52. doi: 10.1210/jc.2012-2539. Epub 2012 Oct 9.

50.

Iron metabolism is associated with adipocyte insulin resistance and plasma adiponectin: the Cohort on Diabetes and Atherosclerosis Maastricht (CODAM) study.

Wlazlo N, van Greevenbroek MM, Ferreira I, Jansen EH, Feskens EJ, van der Kallen CJ, Schalkwijk CG, Bravenboer B, Stehouwer CD.

Diabetes Care. 2013 Feb;36(2):309-15. doi: 10.2337/dc12-0505. Epub 2012 Sep 6.

Supplemental Content

Loading ...
Support Center